Plasma ceramides are altered in MCI and predict cognitive decline and hippocampal volume loss

BACKGROUND: A blood-based biomarker of Alzheimer disease (AD) would be superior to CSF and neuroimaging measures in terms of cost, invasiveness and feasibility for repeated measures. We previously reported blood ceramides varied in relation to timing of memory impairment in a population-based study....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mielke, Michelle M., Haughey, Norman J., Bandaru, Veera Venkata Ratnam, Schech, Steven, Carrick, Richard, Carlson, Michelle C., Mori, Susumu, Miller, Michael I., Ceritoglu, Can, Brown, Timothy, Albert, Marilyn, Lyketsos, Constantine G.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2933928/
https://ncbi.nlm.nih.gov/pubmed/20813340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2010.03.014
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires